RESUMO
BACKGROUND: Over the past several decades, the age of pubertal onset in girls has shifted downward worldwide. As early pubertal onset is associated with increased risky behavior and psychological issues during adolescence and cardiometabolic disease and cancer in adulthood, this is an important public health concern. Exposure to endocrine disrupting chemicals during critical windows of in utero development may play a role in this trend. Our objective was to investigate trimester-specific phthalate and BPA exposure in relation to pubertal development among girls in the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) birth cohort. METHODS: We measured maternal urinary phthalate metabolites and BPA in samples collected during the first, second, and third trimesters of pregnancy. To assess reproductive development among their female children, we measured serum testosterone, estradiol, dehydroepiandrosterone sulfate (DHEA-S), inhibin B, and sex hormone-binding globulin (SHBG), and assessed sexual maturation, including Tanner staging for breast and pubic hair development and menarche status, at age 8-13 years (n = 120). We used linear and logistic regression to examine measures of trimester-specific in utero exposure as predictors of peripubertal hormone levels and pubertal onset, respectively. In secondary analyses, we evaluated estimated exposure at the midpoint of the first trimester and rates of change in exposure across pregnancy in relation to outcomes. RESULTS: Several phthalate metabolites measured throughout in utero development were associated with higher serum testosterone concentrations, while a number of metabolites measured in the third trimester were associated with higher DHEA-S. For example, an interquartile range (IQR) increase in mean monoethyl phthalate (MEP) levels across pregnancy was associated with 44% higher peripubertal testosterone (95% CI: 13-83%), while an IQR increase in di-2-ethylhexyl phthalate metabolites (ΣDEHP) specifically in the third trimester was associated with 25% higher DHEA-S (95%CI: 4.7-47%). In IQR increase in mean mono-2-ethylhexyl phthalate (MEHP) levels across pregnancy was associated with lower odds of having a Tanner Stage >1 for breast development (OR = 0.32, 95%CI: 0.11-0.95), while MEHP in the third trimester was associated with higher odds of having a Tanner Stage >1 for pubic hair development (OR = 3.76, 95%CI: 1.1-12.8). Results from secondary analyses were consistent with findings from our main analysis. CONCLUSION: These findings suggest that female reproductive development may be more vulnerable to the effects of phthalate or BPA exposure during specific critical periods of in utero development. This highlights the need for comprehensive characterizations of in utero exposure and consideration of windows of susceptibility in developmental epidemiological studies. Future research should consider repeated measures of in utero phthalate and BPA exposure within each trimester and across pregnancy.
Assuntos
Compostos Benzidrílicos/toxicidade , Disruptores Endócrinos/toxicidade , Exposição Ambiental , Poluentes Ambientais/toxicidade , Fenóis/toxicidade , Ácidos Ftálicos/toxicidade , Maturidade Sexual/efeitos dos fármacos , Adolescente , Criança , Feminino , Humanos , Estudos Longitudinais , México , GravidezRESUMO
OBJECTIVE: To compare self-report and physician assessments of sexual maturation against serum hormone markers to evaluate the hypothesis that the validity of self-assessed sexual maturation is underestimated in traditional validation studies. STUDY DESIGN: We adapted a self-assessment instrument that 248 Mexican children and adolescents, aged 8-13 years, completed. The participants were examined by a trained pediatrician and provided fasting blood samples for measurement of reproductive hormones (eg, testosterone, estradiol, sex hormone-binding globulin, inhibin B) and other hormones (eg, C-peptide, insulin-like growth factor 1, leptin, dehydroepiandrosterone sulfate) known to change during adolescence. Spearman correlations (r) were calculated among the average rank of all hormones and self-assessed and physician-assessed Tanner stage. The method of triads was used to assess the validity of self-reports by estimating correlations between self-assessments and true but unobservable sexual maturation based on all available data. Bootstrap sampling was used to construct 95% CIs. RESULTS: The validity of self-reported genitalia staging for boys was modest (r = 0.50; 95% CI, 0.31-0.65) and inferior to physician assessment (r = 0.75; 95% CI, 0.56-0.93). Breast stage was well reported (r = 0.89; 95% CI, 0.79-0.97) and superior to physician assessment (r = 0.80; 95% CI, 0.70-0.89). Pubic hair stage reported by boys (r = 0.91; 95% CI, 0.79-0.99) and girls (r = 0.99; 95% CI, 0.96-1.00) was superior to physician assessment (r = 0.79; 95% CI, 0.57-0.97 and r = 0.91; 95% CI, 0.83-0.97, respectively). CONCLUSION: Self-assessment can be validly used in epidemiologic studies for evaluating sexual maturation in children; however, physician assessment may be necessary for accurate assessment of genitalia development in boys.
Assuntos
Hormônios Esteroides Gonadais/sangue , Autoavaliação (Psicologia) , Maturidade Sexual , Adolescente , Desenvolvimento do Adolescente , Criança , Estudos de Coortes , Feminino , Humanos , Masculino , Valor Preditivo dos Testes , Puberdade , Reprodutibilidade dos TestesRESUMO
El parto pretérmino ha sido y continúa siendo uno de los mayores problemas en obstetricia. Es la causa más frecuente de mortalidad neonatal y origina una mortalidad elevada en los productos que sobreviven. La presencia de vaginosis bacteriana y otras infecciones genitales se asocia con aumento en el riesgo de parto pretérmino. Las citoquinas liberan prostaglandinas y han implicadas como causa de actividad uterina. Recientemente, se han desarrollado nuevos métodos para detectar el problema; tales como la ultrasonografía transvaginal y las mediciones de fibronectina fetal a nivel cervical. El atosibán, las citoquinas, el trinitrato de glicerilo y otros medicamentos se han propuesto como nuevos tratamiento y están bajo investigación. Estos fármacos permitirán un tratamiento eficaz con pocos efectos colaterales. La administración prenatal de TRH no se recomienda para uso clínico generalizado. Sin embargo, la aplicación prenatal de corticoesteroides a fetos con riesgo de nacer prematuramente; no solamente reduce el riesgo de síndrome de dificultad respiratoria, sino que disminuye de manera importante la mortalidad por hemorragia intraventricular
Assuntos
Humanos , Feminino , Gravidez , Recém-Nascido , Contração Uterina/fisiologia , Citocinas/fisiologia , Mortalidade Infantil , Recém-Nascido Prematuro , Trabalho de Parto , Trabalho de Parto Prematuro , Trabalho de Parto Prematuro/tratamento farmacológico , Trabalho de Parto Prematuro/etiologia , Ocitocina/efeitos dos fármacos , Ocitocina/fisiologia , Complicações Infecciosas na GravidezRESUMO
Con el objeto de señalar la importancia del examen nasal neonatal, se evaluaron los recién nacidos de 100 partos consecutivos, en la unidad tocoquirúrgica del hospital ABC, durante un periodo de seis semanas. Se propone un protocolo de examen rinológico externo e interno que puede ser realizado por el personal de pediatría durante la evaluación neonatal rutinaria, con posibilidad de consulta al especialista otorrinolaringólogo, si fuese requerido. De un total de 58 niñas y 42 niños recién nacidos, el 48 por ciento presentó algún hallazgo positivo de trauma nasal. Los bebés se dividieron en tres grupos: nacidos por cesárea, por parto eutócico o por parto distócico. En cada grupo se cuantificaron los hallazgos para comparación. Solamente un caso presentó patología nasal lo suficientemente severa como para requerir reparación. Obviamente, es importante el seguimiento de los niños para determinar la posible repercusión de los hallazgos traumáticos en el crecimiento y desarrollo de la nariz